Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference
September 19 2017 - 4:05PM
YASTEST
GAITHERSBURG, Md., Sept. 19, 2017
(GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced
the Company will present at the Ladenburg Thalmann 2017 Healthcare
Conference.
Presentation details are as follows:
Date: Tuesday, September 26, 2017
Time: 11:00 - 11:25 am ET
Location: Track 5, Montmartre, Sofitel Hotel, New York
City
Live webcast: www.novavax.com, "Investors"/"Events"
A replay of the presentation will also be
accessible under the "Investors/Events" section of the Novavax
website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
biotechnology company committed to delivering novel products to
prevent a broad range of infectious diseases. Our recombinant
nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global
health through safe and effective vaccines. Additional information
about Novavax is available on the Company's website,
novavax.com.
Contact:
Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor & Media Relations
ir@novavax.com
240-268-2000
Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506
Media
Russo Partners, LLC
David Schull
Maggie Beller
david.schull@russopartnersllc.com
maggie.beller@russopartnersllc.com
212-845-4271
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024